SOLVSolventum
Price
+30%1YEnd-of-day closes, not the intraday tick.
Solventum Corporation ("Solventum," "we," "our," "us," or the "Company"), is a leading global healthcare company developing, manufacturing, and commercializing a broad portfolio of solutions that leverages deep material science, data science, and digital capabilities to address critical customer and patient needs. We constantly seek to enable the improvement of standards of care and move healthcare forward with innovation powered by insights, clinical intelligence, technology, and manufacturing expertise.
In the company’s own words · 10-K filed Feb 27, 2026 · SEC EDGAR
Charts
As reported to the SEC, without any scoring.
Business segments
Q3 2026 · $1.20BThe company’s own SEC segment disclosure.
- MedSurg$528.0M44%
- Health Information Systems$356.0M30%
- Dental Solutions$317.0M26%
Solventum (SOLV) reported revenue of $1.95B in Q3 2026 (quarter ended Sep 30, 2026), down 7.0% from the same quarter a year earlier. That came with a gross margin of 54% and net loss of $12M. For the full year FY2025, revenue was $8.32B (+0.9% year on year) and net income $1.56B. Its largest segment in Q3 2026 was MedSurg at $528M, 44% of the disclosed total, ahead of Health Information Systems at 30%. The next results filing is expected around Feb 25, 2027, the same week as a year ago.
What the company said
The company's own words from its current reports to the SEC, newest first
- Nov 5, 2026Solventum Reports Third Quarter 2026 Financial Results.Earnings release · press release
- Aug 5, 2026Solventum Reports Second Quarter 2026 Financial Results.Earnings release · press release
- Aug 5, 2026The information furnished pursuant to this.Regulation FD disclosure · Form 8-K
Quoted from SEC EDGAR filings. A current report is filed within four business days of the event it describes.
Medical Instruments & Supplies
The closest names by size in the same industry